Medi Assist Ser. Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹242 Cr +3.9% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
MA

Medi Assist Ser.

Q3 FY26Insurance

Medi Assist Healthcare Services Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹240Cr
+29% YoY
+3% QoQ
Net profit
₹4Cr
−86.7% YoY
−50% QoQ
Margin
19%
−2 pp YoY
+2 pp QoQ
Price₹355
Market cap₹2.7K Cr
P/E27.3

The short version

Growth expected from ongoing migration of insurer volumes to the MAtrix platform, with full volume ramp-up anticipated in the next 2-3 quarters. The company expects to improve core EBITDA margins over the next 2 to 3 quarters through disciplined execution and integration of Paramount (Page 18).

From Medi Assist Ser.'s Q3 FY26 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

  • Growth expected from ongoing migration of insurer volumes to the MAtrix platform, with full volume ramp-up anticipated in the next 2-3 quarters.
  • Retail premiums are expected to recover and grow post a 2-3 quarter typical reallocation cycle in PSU portfolios.
  • Expansion of technology-led revenue streams, especially from SaaS products like MAtrix and AI-driven solutions such as MAven Guard, with tech revenues growing 81.5% over 9 months and now making ~2.5% of total revenue.
  • Increasing market penetration with new insurer partnerships, both in India and internationally, including travel and private medical insurance segments.

2 more points from Medi Assist Ser.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

The company expects to improve core EBITDA margins over the next 2 to 3 quarters through disciplined…

Locked: what Medi Assist Ser. said on margins

Also locked on this page: fundraising

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

  • The company has become debt-free, providing capital availability to judiciously deploy in services to enhance customer experiences.
  • There is a strong focus on technology deployments, particularly on expanding the tech SaaS revenue model (e.g., MAtrix platform, MAven Guard, and other AI capabilities).
  • Investments are underway in digital infrastructure and tech platforms, including the technology transformation related to Star Health integration.
  • AI-led products and technology-driven services, such as fraud, waste and abuse detection (MAven Guard) and cashless experience improvement (Raksha Prime), are areas of strategic investment.

2 more points from Medi Assist Ser.'s call on capex

Create a free account to keep reading this call

Top-ranked in Insurance

Ranked on what management guided this quarter

Guidance-ranked
1Niva Bupa Health
Rev 2Mar 3
2Max Financial
Rev 3Mar 2
3
Rev 3Mar 3
Sign up free to see 1 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company has become debt-free as of January 2026, having repaid INR 39.4 crores of debt.

Locked: what Medi Assist Ser. said on fundraising

Also locked on this page: margins

Free account, 30 seconds. No card needed.

Order Book & Pipeline

Relevant insights include: - Contract liabilities increased to INR 280.8 crores from INR 227 crores YoY, indicating improvement in new business acquired (Page 12). - There is ongoing migration and scaling up of insurer volumes on the MAtrix platform, with expectations to reach full volume across clients in the next 2-3 quarters (Pages 15-16).

2 more points from Medi Assist Ser.'s call on order book

Create a free account to keep reading this call

Medi Assist Ser. — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Medi Assist Ser. Q3 FY26 results — key figures

Medi Assist Ser. Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue240186+29%233+3%
Operating profit (EBITDA)4540+12.5%40+12.5%
Operating margin19%21%-2 pp17%+2 pp
Profit before tax827-70.4%13-38.5%
Net profit (PAT)430-86.7%8-50%
EPS (₹)0.564.19-86.6%1.13-50.4%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹242 Cr, net profit ₹22 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Insurance this season

  • HDFC Life Insurance Company (Q3 FY26)

    Profit after tax (PAT) grew 7% to Rs. Key concall takeaways from HDFC Life Insurance Company Ltd's Q3 FY26 earnings call — and how it ranks against sector…

  • Canara HSBC (Q3 FY26)

    Annuity business AP grew 34% year-on-year, with focus on deferred annuity for profitable growth. Key concall takeaways from Canara HSBC Life Insurance Company…

  • Niva Bupa Health (Q3 FY26)

    Overall growth in Q3 was 31%, and 26% for the first 9 months, indicating strong upward momentum. Key concall takeaways from Niva Bupa Health Insurance Company…

  • Life Insurance (Q3 FY26)

    Bancassurance and alternate channels have shown strong premium growth (40%+ for banks and 126%+ for alternate channels), with efforts to further enhance these…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Medi Assist Ser. and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Medi Assist Ser. Q3 FY26 results?

Growth expected from ongoing migration of insurer volumes to the MAtrix platform, with full volume ramp-up anticipated in the next 2-3 quarters. The company expects to improve core EBITDA margins over the next 2 to 3 quarters through disciplined execution and integration of Paramount (Page 18).

What is Medi Assist Ser. share price analysis?

Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 27.3 with a market cap of ₹2,695 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medi Assist Ser. planning capital expenditure?

The company has become debt-free, providing capital availability to judiciously deploy in services to enhance customer experiences.

Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.